PubMed:11009181 / 63-158
Annnotations
LitCoin-entities
| Id | Subject | Object | Predicate | Lexical cue | db_id |
|---|---|---|---|---|---|
| 359 | 0-11 | ChemicalEntity | denotes | Apomorphine | MESH:D001058 |
| 360 | 26-43 | ChemicalEntity | denotes | dopaminergic drug | MESH:D004298 |
| 361 | 75-94 | DiseaseOrPhenotypicFeature | denotes | Parkinson's disease | MESH:D010300 |
LitCoin-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T2 | 0-95 | Sentence | denotes | Apomorphine was the first dopaminergic drug ever used to treat symptoms of Parkinson's disease. |
LitCoin_Mondo
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T2 | 75-94 | DiseaseOrPhenotypicFeature | denotes | Parkinson's disease | 0005180 |
LitCoin-Disease-MeSH
| Id | Subject | Object | Predicate | Lexical cue | originalLabel |
|---|---|---|---|---|---|
| T2 | 75-94 | DiseaseOrPhenotypicFeature | denotes | Parkinson's disease | D010300 |
LitCoin_Mondo_095
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T2 | 44-48 | DiseaseOrPhenotypicFeature | denotes | ever | 0009176 |
| T3 | 75-94 | DiseaseOrPhenotypicFeature | denotes | Parkinson's disease | 0005180 |
LitCoin-MeSH-Disease-2
| Id | Subject | Object | Predicate | Lexical cue | ID: |
|---|---|---|---|---|---|
| T2 | 75-94 | DiseaseOrPhenotypicFeature | denotes | Parkinson's disease | D010300 |
LitCoin-MONDO_bioort2019
| Id | Subject | Object | Predicate | Lexical cue | #label |
|---|---|---|---|---|---|
| T2 | 75-94 | DiseaseOrPhenotypicFeature | denotes | Parkinson's disease | D010300 |
LitCoin-Chemical-MeSH-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | ID: |
|---|---|---|---|---|---|
| T3 | 0-11 | ChemicalEntity | denotes | Apomorphine | D001058|http://purl.obolibrary.org/obo/CHEBI_48538 |
| T5 | 26-43 | ChemicalEntity | denotes | dopaminergic drug | ChemicalEntity |
LitCoin-training-merged
| Id | Subject | Object | Predicate | Lexical cue | #label | ID: |
|---|---|---|---|---|---|---|
| T5 | 26-43 | ChemicalEntity | denotes | dopaminergic drug | ChemicalEntity | |
| T3 | 0-11 | ChemicalEntity | denotes | Apomorphine | http://purl.obolibrary.org/obo/CHEBI_48538|D001058 | |
| T2 | 75-94 | DiseaseOrPhenotypicFeature | denotes | Parkinson's disease | D010300 |